Антибиотики и Химиотерапия (May 2020)

Preclinical Trials of L-Lysine-a-Oxidase, an Antitumor Enzyme

  • V. M. Podboronov,
  • A. E. Kuzovnikov,
  • A. K. Zaitseva,
  • I. P. Smirnova

Journal volume & issue
Vol. 55, no. 9-10
pp. 33 – 36

Abstract

Read online

The effect of L-lysine-a-oxidase from a representative of the Trichoderma genus on the humoral immune response to protein antigens was studied. It was shown that repeated fife-fold intravenous administrations of L-lysine-a-oxidase in a dose of 35 U/kg had no depressive action on the humoral immunity. The enzyme had no suppressive effect on the delayed type hypersensitivity to xenogenous erythrocytes. The use of L-lysine-a-oxidase in a therapeutic dose or in a twice as higher dose had no reliable effect on the leukocyte migration capacity vs. the control.

Keywords